 | • レポートコード：MRC308GR11415 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の骨代謝薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の骨代謝薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 骨代謝薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
骨代謝薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・ゾレドロン酸、イバンドロン酸、アレンドロン酸、パミドロン酸、その他
用途別セグメント
・病院、診療所、その他
主要な市場プレーヤー
・Novartis、Organon、Atnahs Pharma、CTTQ、Jiangsu Hengrui Pharmaceuticals、Nanjing Hencer Pharmaceutical、Chengdu Easton Biopharmaceuticals、Shenzhen Neptunus Pharmaceutical、Luye Pharma、Chengdu Gowell Biopharmaceutial、Sichuan Hairong Pharmaceutical
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、骨代謝薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な骨代謝薬メーカーの企業概要、2019年～2022年までの骨代謝薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な骨代謝薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別骨代謝薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの骨代謝薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での骨代謝薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および骨代謝薬の産業チェーンを掲載しています。
・第14、15章では、骨代謝薬の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 骨代謝薬の概要
– 種類別分析（2018年vs2022年vs2029年）：ゾレドロン酸、イバンドロン酸、アレンドロン酸、パミドロン酸、その他
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、その他
– 世界の骨代謝薬市場規模・予測
– 世界の骨代謝薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Novartis、Organon、Atnahs Pharma、CTTQ、Jiangsu Hengrui Pharmaceuticals、Nanjing Hencer Pharmaceutical、Chengdu Easton Biopharmaceuticals、Shenzhen Neptunus Pharmaceutical、Luye Pharma、Chengdu Gowell Biopharmaceutial、Sichuan Hairong Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：ゾレドロン酸、イバンドロン酸、アレンドロン酸、パミドロン酸、その他
・用途別分析2018年-2029年：病院、診療所、その他
・骨代謝薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・骨代謝薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・骨代謝薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・骨代謝薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・骨代謝薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Drugs for Bone Metabolism
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Drugs for Bone Metabolism Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Zoledronic Acid
1.3.3 Ibandronic Acid
1.3.4 Alendronic Acid
1.3.5 Pamidronic Acid
1.3.6 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Drugs for Bone Metabolism Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Drugs for Bone Metabolism Market Size & Forecast
1.5.1 Global Drugs for Bone Metabolism Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Drugs for Bone Metabolism Sales Quantity (2018-2029)
1.5.3 Global Drugs for Bone Metabolism Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Drugs for Bone Metabolism Product and Services
2.1.4 Novartis Drugs for Bone Metabolism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Organon
2.2.1 Organon Details
2.2.2 Organon Major Business
2.2.3 Organon Drugs for Bone Metabolism Product and Services
2.2.4 Organon Drugs for Bone Metabolism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Organon Recent Developments/Updates
2.3 Atnahs Pharma
2.3.1 Atnahs Pharma Details
2.3.2 Atnahs Pharma Major Business
2.3.3 Atnahs Pharma Drugs for Bone Metabolism Product and Services
2.3.4 Atnahs Pharma Drugs for Bone Metabolism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Atnahs Pharma Recent Developments/Updates
2.4 CTTQ
2.4.1 CTTQ Details
2.4.2 CTTQ Major Business
2.4.3 CTTQ Drugs for Bone Metabolism Product and Services
2.4.4 CTTQ Drugs for Bone Metabolism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 CTTQ Recent Developments/Updates
2.5 Jiangsu Hengrui Pharmaceuticals
2.5.1 Jiangsu Hengrui Pharmaceuticals Details
2.5.2 Jiangsu Hengrui Pharmaceuticals Major Business
2.5.3 Jiangsu Hengrui Pharmaceuticals Drugs for Bone Metabolism Product and Services
2.5.4 Jiangsu Hengrui Pharmaceuticals Drugs for Bone Metabolism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
2.6 Nanjing Hencer Pharmaceutical
2.6.1 Nanjing Hencer Pharmaceutical Details
2.6.2 Nanjing Hencer Pharmaceutical Major Business
2.6.3 Nanjing Hencer Pharmaceutical Drugs for Bone Metabolism Product and Services
2.6.4 Nanjing Hencer Pharmaceutical Drugs for Bone Metabolism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Nanjing Hencer Pharmaceutical Recent Developments/Updates
2.7 Chengdu Easton Biopharmaceuticals
2.7.1 Chengdu Easton Biopharmaceuticals Details
2.7.2 Chengdu Easton Biopharmaceuticals Major Business
2.7.3 Chengdu Easton Biopharmaceuticals Drugs for Bone Metabolism Product and Services
2.7.4 Chengdu Easton Biopharmaceuticals Drugs for Bone Metabolism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Chengdu Easton Biopharmaceuticals Recent Developments/Updates
2.8 Shenzhen Neptunus Pharmaceutical
2.8.1 Shenzhen Neptunus Pharmaceutical Details
2.8.2 Shenzhen Neptunus Pharmaceutical Major Business
2.8.3 Shenzhen Neptunus Pharmaceutical Drugs for Bone Metabolism Product and Services
2.8.4 Shenzhen Neptunus Pharmaceutical Drugs for Bone Metabolism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Shenzhen Neptunus Pharmaceutical Recent Developments/Updates
2.9 Luye Pharma
2.9.1 Luye Pharma Details
2.9.2 Luye Pharma Major Business
2.9.3 Luye Pharma Drugs for Bone Metabolism Product and Services
2.9.4 Luye Pharma Drugs for Bone Metabolism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Luye Pharma Recent Developments/Updates
2.10 Chengdu Gowell Biopharmaceutial
2.10.1 Chengdu Gowell Biopharmaceutial Details
2.10.2 Chengdu Gowell Biopharmaceutial Major Business
2.10.3 Chengdu Gowell Biopharmaceutial Drugs for Bone Metabolism Product and Services
2.10.4 Chengdu Gowell Biopharmaceutial Drugs for Bone Metabolism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Chengdu Gowell Biopharmaceutial Recent Developments/Updates
2.11 Sichuan Hairong Pharmaceutical
2.11.1 Sichuan Hairong Pharmaceutical Details
2.11.2 Sichuan Hairong Pharmaceutical Major Business
2.11.3 Sichuan Hairong Pharmaceutical Drugs for Bone Metabolism Product and Services
2.11.4 Sichuan Hairong Pharmaceutical Drugs for Bone Metabolism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Sichuan Hairong Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Drugs for Bone Metabolism by Manufacturer
3.1 Global Drugs for Bone Metabolism Sales Quantity by Manufacturer (2018-2023)
3.2 Global Drugs for Bone Metabolism Revenue by Manufacturer (2018-2023)
3.3 Global Drugs for Bone Metabolism Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Drugs for Bone Metabolism by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Drugs for Bone Metabolism Manufacturer Market Share in 2022
3.4.2 Top 6 Drugs for Bone Metabolism Manufacturer Market Share in 2022
3.5 Drugs for Bone Metabolism Market: Overall Company Footprint Analysis
3.5.1 Drugs for Bone Metabolism Market: Region Footprint
3.5.2 Drugs for Bone Metabolism Market: Company Product Type Footprint
3.5.3 Drugs for Bone Metabolism Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Drugs for Bone Metabolism Market Size by Region
4.1.1 Global Drugs for Bone Metabolism Sales Quantity by Region (2018-2029)
4.1.2 Global Drugs for Bone Metabolism Consumption Value by Region (2018-2029)
4.1.3 Global Drugs for Bone Metabolism Average Price by Region (2018-2029)
4.2 North America Drugs for Bone Metabolism Consumption Value (2018-2029)
4.3 Europe Drugs for Bone Metabolism Consumption Value (2018-2029)
4.4 Asia-Pacific Drugs for Bone Metabolism Consumption Value (2018-2029)
4.5 South America Drugs for Bone Metabolism Consumption Value (2018-2029)
4.6 Middle East and Africa Drugs for Bone Metabolism Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Drugs for Bone Metabolism Sales Quantity by Type (2018-2029)
5.2 Global Drugs for Bone Metabolism Consumption Value by Type (2018-2029)
5.3 Global Drugs for Bone Metabolism Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Drugs for Bone Metabolism Sales Quantity by Application (2018-2029)
6.2 Global Drugs for Bone Metabolism Consumption Value by Application (2018-2029)
6.3 Global Drugs for Bone Metabolism Average Price by Application (2018-2029)
7 North America
7.1 North America Drugs for Bone Metabolism Sales Quantity by Type (2018-2029)
7.2 North America Drugs for Bone Metabolism Sales Quantity by Application (2018-2029)
7.3 North America Drugs for Bone Metabolism Market Size by Country
7.3.1 North America Drugs for Bone Metabolism Sales Quantity by Country (2018-2029)
7.3.2 North America Drugs for Bone Metabolism Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Drugs for Bone Metabolism Sales Quantity by Type (2018-2029)
8.2 Europe Drugs for Bone Metabolism Sales Quantity by Application (2018-2029)
8.3 Europe Drugs for Bone Metabolism Market Size by Country
8.3.1 Europe Drugs for Bone Metabolism Sales Quantity by Country (2018-2029)
8.3.2 Europe Drugs for Bone Metabolism Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Drugs for Bone Metabolism Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Drugs for Bone Metabolism Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Drugs for Bone Metabolism Market Size by Region
9.3.1 Asia-Pacific Drugs for Bone Metabolism Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Drugs for Bone Metabolism Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Drugs for Bone Metabolism Sales Quantity by Type (2018-2029)
10.2 South America Drugs for Bone Metabolism Sales Quantity by Application (2018-2029)
10.3 South America Drugs for Bone Metabolism Market Size by Country
10.3.1 South America Drugs for Bone Metabolism Sales Quantity by Country (2018-2029)
10.3.2 South America Drugs for Bone Metabolism Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Drugs for Bone Metabolism Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Drugs for Bone Metabolism Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Drugs for Bone Metabolism Market Size by Country
11.3.1 Middle East & Africa Drugs for Bone Metabolism Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Drugs for Bone Metabolism Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Drugs for Bone Metabolism Market Drivers
12.2 Drugs for Bone Metabolism Market Restraints
12.3 Drugs for Bone Metabolism Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Drugs for Bone Metabolism and Key Manufacturers
13.2 Manufacturing Costs Percentage of Drugs for Bone Metabolism
13.3 Drugs for Bone Metabolism Production Process
13.4 Drugs for Bone Metabolism Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Drugs for Bone Metabolism Typical Distributors
14.3 Drugs for Bone Metabolism Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Drugs for Bone Metabolism Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Drugs for Bone Metabolism Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Drugs for Bone Metabolism Product and Services
Table 6. Novartis Drugs for Bone Metabolism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis Recent Developments/Updates
Table 8. Organon Basic Information, Manufacturing Base and Competitors
Table 9. Organon Major Business
Table 10. Organon Drugs for Bone Metabolism Product and Services
Table 11. Organon Drugs for Bone Metabolism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Organon Recent Developments/Updates
Table 13. Atnahs Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Atnahs Pharma Major Business
Table 15. Atnahs Pharma Drugs for Bone Metabolism Product and Services
Table 16. Atnahs Pharma Drugs for Bone Metabolism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Atnahs Pharma Recent Developments/Updates
Table 18. CTTQ Basic Information, Manufacturing Base and Competitors
Table 19. CTTQ Major Business
Table 20. CTTQ Drugs for Bone Metabolism Product and Services
Table 21. CTTQ Drugs for Bone Metabolism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. CTTQ Recent Developments/Updates
Table 23. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Jiangsu Hengrui Pharmaceuticals Major Business
Table 25. Jiangsu Hengrui Pharmaceuticals Drugs for Bone Metabolism Product and Services
Table 26. Jiangsu Hengrui Pharmaceuticals Drugs for Bone Metabolism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 28. Nanjing Hencer Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Nanjing Hencer Pharmaceutical Major Business
Table 30. Nanjing Hencer Pharmaceutical Drugs for Bone Metabolism Product and Services
Table 31. Nanjing Hencer Pharmaceutical Drugs for Bone Metabolism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Nanjing Hencer Pharmaceutical Recent Developments/Updates
Table 33. Chengdu Easton Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Chengdu Easton Biopharmaceuticals Major Business
Table 35. Chengdu Easton Biopharmaceuticals Drugs for Bone Metabolism Product and Services
Table 36. Chengdu Easton Biopharmaceuticals Drugs for Bone Metabolism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Chengdu Easton Biopharmaceuticals Recent Developments/Updates
Table 38. Shenzhen Neptunus Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Shenzhen Neptunus Pharmaceutical Major Business
Table 40. Shenzhen Neptunus Pharmaceutical Drugs for Bone Metabolism Product and Services
Table 41. Shenzhen Neptunus Pharmaceutical Drugs for Bone Metabolism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Shenzhen Neptunus Pharmaceutical Recent Developments/Updates
Table 43. Luye Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Luye Pharma Major Business
Table 45. Luye Pharma Drugs for Bone Metabolism Product and Services
Table 46. Luye Pharma Drugs for Bone Metabolism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Luye Pharma Recent Developments/Updates
Table 48. Chengdu Gowell Biopharmaceutial Basic Information, Manufacturing Base and Competitors
Table 49. Chengdu Gowell Biopharmaceutial Major Business
Table 50. Chengdu Gowell Biopharmaceutial Drugs for Bone Metabolism Product and Services
Table 51. Chengdu Gowell Biopharmaceutial Drugs for Bone Metabolism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Chengdu Gowell Biopharmaceutial Recent Developments/Updates
Table 53. Sichuan Hairong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Sichuan Hairong Pharmaceutical Major Business
Table 55. Sichuan Hairong Pharmaceutical Drugs for Bone Metabolism Product and Services
Table 56. Sichuan Hairong Pharmaceutical Drugs for Bone Metabolism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Sichuan Hairong Pharmaceutical Recent Developments/Updates
Table 58. Global Drugs for Bone Metabolism Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Drugs for Bone Metabolism Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Drugs for Bone Metabolism Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Drugs for Bone Metabolism, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Drugs for Bone Metabolism Production Site of Key Manufacturer
Table 63. Drugs for Bone Metabolism Market: Company Product Type Footprint
Table 64. Drugs for Bone Metabolism Market: Company Product Application Footprint
Table 65. Drugs for Bone Metabolism New Market Entrants and Barriers to Market Entry
Table 66. Drugs for Bone Metabolism Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Drugs for Bone Metabolism Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Drugs for Bone Metabolism Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Drugs for Bone Metabolism Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Drugs for Bone Metabolism Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Drugs for Bone Metabolism Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Drugs for Bone Metabolism Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Drugs for Bone Metabolism Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Drugs for Bone Metabolism Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Drugs for Bone Metabolism Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Drugs for Bone Metabolism Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Drugs for Bone Metabolism Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Drugs for Bone Metabolism Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Drugs for Bone Metabolism Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Drugs for Bone Metabolism Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Drugs for Bone Metabolism Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Drugs for Bone Metabolism Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Drugs for Bone Metabolism Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Drugs for Bone Metabolism Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Drugs for Bone Metabolism Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Drugs for Bone Metabolism Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Drugs for Bone Metabolism Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Drugs for Bone Metabolism Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Drugs for Bone Metabolism Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Drugs for Bone Metabolism Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Drugs for Bone Metabolism Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Drugs for Bone Metabolism Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Drugs for Bone Metabolism Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Drugs for Bone Metabolism Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Drugs for Bone Metabolism Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Drugs for Bone Metabolism Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Drugs for Bone Metabolism Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Drugs for Bone Metabolism Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Drugs for Bone Metabolism Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Drugs for Bone Metabolism Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Drugs for Bone Metabolism Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Drugs for Bone Metabolism Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Drugs for Bone Metabolism Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Drugs for Bone Metabolism Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Drugs for Bone Metabolism Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Drugs for Bone Metabolism Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Drugs for Bone Metabolism Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Drugs for Bone Metabolism Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Drugs for Bone Metabolism Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Drugs for Bone Metabolism Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Drugs for Bone Metabolism Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Drugs for Bone Metabolism Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Drugs for Bone Metabolism Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Drugs for Bone Metabolism Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Drugs for Bone Metabolism Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Drugs for Bone Metabolism Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Drugs for Bone Metabolism Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Drugs for Bone Metabolism Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Drugs for Bone Metabolism Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Drugs for Bone Metabolism Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Drugs for Bone Metabolism Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Drugs for Bone Metabolism Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Drugs for Bone Metabolism Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Drugs for Bone Metabolism Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Drugs for Bone Metabolism Raw Material
Table 126. Key Manufacturers of Drugs for Bone Metabolism Raw Materials
Table 127. Drugs for Bone Metabolism Typical Distributors
Table 128. Drugs for Bone Metabolism Typical Customers
List of Figures
Figure 1. Drugs for Bone Metabolism Picture
Figure 2. Global Drugs for Bone Metabolism Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Drugs for Bone Metabolism Consumption Value Market Share by Type in 2022
Figure 4. Zoledronic Acid Examples
Figure 5. Ibandronic Acid Examples
Figure 6. Alendronic Acid Examples
Figure 7. Pamidronic Acid Examples
Figure 8. Other Examples
Figure 9. Global Drugs for Bone Metabolism Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Drugs for Bone Metabolism Consumption Value Market Share by Application in 2022
Figure 11. Hospital Examples
Figure 12. Clinic Examples
Figure 13. Other Examples
Figure 14. Global Drugs for Bone Metabolism Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Drugs for Bone Metabolism Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Drugs for Bone Metabolism Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Drugs for Bone Metabolism Average Price (2018-2029) & (US$/Unit)
Figure 18. Global Drugs for Bone Metabolism Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Drugs for Bone Metabolism Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Drugs for Bone Metabolism by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Drugs for Bone Metabolism Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Drugs for Bone Metabolism Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Drugs for Bone Metabolism Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Drugs for Bone Metabolism Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Drugs for Bone Metabolism Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Drugs for Bone Metabolism Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Drugs for Bone Metabolism Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Drugs for Bone Metabolism Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Drugs for Bone Metabolism Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Drugs for Bone Metabolism Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Drugs for Bone Metabolism Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Drugs for Bone Metabolism Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global Drugs for Bone Metabolism Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Drugs for Bone Metabolism Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Drugs for Bone Metabolism Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America Drugs for Bone Metabolism Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Drugs for Bone Metabolism Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Drugs for Bone Metabolism Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Drugs for Bone Metabolism Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Drugs for Bone Metabolism Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Drugs for Bone Metabolism Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Drugs for Bone Metabolism Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Drugs for Bone Metabolism Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Drugs for Bone Metabolism Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Drugs for Bone Metabolism Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Drugs for Bone Metabolism Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Drugs for Bone Metabolism Consumption Value Market Share by Region (2018-2029)
Figure 56. China Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Drugs for Bone Metabolism Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Drugs for Bone Metabolism Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Drugs for Bone Metabolism Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Drugs for Bone Metabolism Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Drugs for Bone Metabolism Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Drugs for Bone Metabolism Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Drugs for Bone Metabolism Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Drugs for Bone Metabolism Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Drugs for Bone Metabolism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Drugs for Bone Metabolism Market Drivers
Figure 77. Drugs for Bone Metabolism Market Restraints
Figure 78. Drugs for Bone Metabolism Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Drugs for Bone Metabolism in 2022
Figure 81. Manufacturing Process Analysis of Drugs for Bone Metabolism
Figure 82. Drugs for Bone Metabolism Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source